Complications and Risks of Adrenalectomy
Laparoscopic adrenalectomy performed by experienced surgeons in specialized centers carries perioperative mortality <0.5% and severe complications <2%, though overall morbidity ranges 5-15% with most being minor complications. 1
Perioperative Mortality and Major Complications
Mortality and severe complications are rare but real:
- Perioperative mortality: <0.5% in specialized centers 1
- Severe complications (hemorrhage requiring transfusion, cardiac/respiratory events): <2% in experienced hands 1
- Mortality increases to ~1% in broader cohorts 2
- Critical caveat: Complication rates are significantly higher outside specialized centers 1
The most recent multicenter UK data (2023) on pheochromocytoma specifically showed 0.5% perioperative mortality with 26.8% experiencing any complication 3. This aligns with guideline estimates but emphasizes that even in high-volume centers, complications remain common.
Common Minor Complications (5-15% incidence)
Most complications are minor and transient:
- Transient parietal hypotonia or hypoesthesia (most common) 1
- Conversion to open surgery: typically <5% 1, though up to 5% in broader series 2
- Intraoperative blood pressure instability requiring intervention: 45% of cases 1
Metabolic and Endocrine Complications
Postoperative electrolyte and hormonal disturbances are frequent and require vigilant monitoring:
Hyperkalemia (15-30% incidence)
- Occurs due to functional mineralocorticoid insufficiency in the contralateral adrenal 1
- Generally moderate and transient, but up to 5% require prolonged fludrocortisone 1
- Prevention strategy: Stop spironolactone and potassium supplementation at surgery; check potassium postoperatively, especially with chronic kidney disease 1
Hypokalemia During Surgery
- Potassium drops 0.5-1 mmol/L intraoperatively without supplementation 1
- Mitigation: Normalize potassium preoperatively with supplementation if needed 1
Adrenal Insufficiency
- Particularly relevant after bilateral adrenalectomy or in patients with mild autonomous cortisol secretion
- Recent 2026 data shows 48% develop suspected adrenal insufficiency after unilateral adrenalectomy for mild autonomous cortisol secretion 4
- Key predictor: Post-dexamethasone suppression test cortisol >5 μg/dL confers 4-fold increased risk of requiring glucocorticoid replacement beyond 1 year 4
Hypoglycemia
- Rebound hypoglycemia can occur postoperatively, particularly after pheochromocytoma resection 2
- Monitoring requirement: Blood glucose levels for 24-48 hours postoperatively 2
Risk Factors for Complications
Multiple patient and procedural factors independently predict worse outcomes:
Patient Factors
- Age-adjusted Charlson Comorbidity Index ≥3: 8-fold increased odds of complications 3
- ASA class 3-4: 2.78-fold increased complications 5
- Diabetes: 2.39-fold increased complications 5
- Age ≥65 years: 2.44-fold increased prolonged hospital stay 5
Tumor Characteristics
- Pheochromocytoma: 4.31-fold increased complications compared to other pathologies 5
- Tumor size ≥6 cm: 2.47-fold increased complications 5
- Malignancy: 8.33-fold increased conversion risk 6
Procedural Factors
- Conversion to open surgery: 5.32-10.34-fold increased complications 3, 5
- Open surgery (planned): 11.69-fold increased complications vs laparoscopic 3
- Surgeon inexperience/non-specialized center: Significantly higher complication rates 1
Rare but Catastrophic Complications
Previously unreported high-grade complications include:
- Complete transection of porta hepatis requiring emergent liver transplantation 7
- Hepatic artery ligation causing recurrent cholangitis and bile duct sclerosis requiring liver transplantation 7
- Ureteral ligation causing hydronephrosis and renal loss 7
- Renal artery ligation causing kidney loss 7
- Wrong organ removal (normal adrenal removed instead of renal mass) 7
These catastrophic events, while extremely rare, underscore the importance of surgeon experience 7.
Long-Term Complications
Chronic Kidney Disease and Metabolic Sequelae
Recent 20-year population data (2026) reveals:
- 2.07-fold increased risk of CKD/renal impairment after adrenalectomy for primary aldosteronism 8
- 1.54-fold increased risk of gout 8
- These risks persist long-term and require ongoing surveillance 8
Tumor Recurrence
- Partial adrenalectomy carries 2.64-fold higher recurrence risk compared to total adrenalectomy 9
- Particularly elevated in pheochromocytoma patients undergoing partial resection 9
- Trade-off: Partial adrenalectomy reduces steroid dependence (RR 0.44) and adrenal insufficiency (RR 0.49) 9
Nelson's Syndrome
- Develops in 28% of Cushing's disease patients after bilateral adrenalectomy 10
Pheochromocytoma-Specific Considerations
Inadequate preoperative blockade increases intraoperative instability:
- Recommend α-adrenergic blockade 7-14 days preoperatively 2
- High-sodium diet and fluid loading to reverse catecholamine-induced volume contraction 2
- Monitoring requirement: Blood pressure, heart rate, and glucose for 24-48 hours postoperatively 2
Hospital Stay and Recovery
In specialized centers:
- Mean hospital stay: 3 days 1
- Selected low-risk patients (age <65, minimal cardiac comorbidity, ≤3 antihypertensives, early-day procedure, residence within 30 minutes) may undergo outpatient surgery 1
- Prolonged stay (≥5 days) predicted by: Charlson ≥3, tumor size, conversion to open, open approach 5
Critical Practice Points
To minimize morbidity and mortality:
Refer to specialized centers with experienced surgeons - This single factor most dramatically reduces complication rates 1
Use laparoscopic approach - Strong recommendation over open surgery 1
For primary aldosteronism patients:
For pheochromocytoma patients:
Risk stratify patients - Those with high Charlson scores, large tumors, pheochromocytoma, or requiring open/converted procedures need heightened vigilance 3, 5
Long-term surveillance - Annual biochemical testing for recurrence/metastasis 2, and monitoring for CKD and metabolic complications 8